Moreover, the direct binding of defined peptide epitopes to MHC molecules makes peptide vaccines valuable tools for identifying novel tumor-specific T cell epitopes, enabling efficient in vitro screening using APCs and T cells or peptide-MHC complex analyses. The gene discussed is HLA-C; the disease is neoplasm.